[Federal Register Volume 89, Number 26 (Wednesday, February 7, 2024)]
[Notices]
[Pages 8433-8434]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02507]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Sole Source Cooperative Agreement To Fund 
the Pan-American Health Organization (PAHO)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $8,000,000, with an expected total funding of 
approximately $50,000,000 over a 5-year period, to the Pan-American 
Health Organization (PAHO). The award will support strengthening 
immunization systems; ensuring polio free certification status; 
maintaining measles, rubella, and neonatal tetanus elimination; and 
prevention of other vaccine-preventable diseases (VPDs) in the Americas 
region. This award builds upon and continues work previously supported 
by PAHO through a cooperative agreement under CDC-RFA-GH-1901, 
``Cooperative Agreement with the Pan American Health Organization: 
Protecting and Strengthening Immunization Programs in the Americas.''

DATES: The period for this award will be May 1, 2024, through April 30, 
2029.

FOR FURTHER INFORMATION CONTACT: Mary A. Mulholland, (Global Health 
Center, Centers for Disease Control and Prevention, 1600 Clifton Rd. 
NE, Atlanta, GA 30333, Telephone: 404-553-7371, Email: 
[email protected].

SUPPLEMENTARY INFORMATION: The sole source award will establish a 
cooperative agreement that will build upon the achievements of past 
cooperative agreements with PAHO, while forging new collaborations to 
strengthen the Expanded Program on Immunization in the Americas as a

[[Page 8434]]

whole. Supported activities will includes development of standards for 
national immunization programs, development of national immunization 
program capacity to prevent, detect and respond to VPDs, and maintain 
the status of polio eradication; rubella, measles, and neonatal tetanus 
elimination; and support the elimination of Hepatitis B. To achieve 
these strategies, the recipient will provide direct technical 
cooperation to Member States through both its regional headquarters and 
country offices.
    PAHO is in a unique position to conduct this work, as it functions 
as the lead specialized health agency within the inter-American system 
and operates as the regional office for the Americas on behalf of the 
World Health Organization (WHO), the UN's specialized health agency, 
with headquarters in Washington DC. Through their presence in the 35 
member countries in the region, PAHO promotes technical cooperation 
between countries and works in partnership with ministries of health 
and other government agencies, civil society organizations, other 
international agencies, universities, social security agencies, 
community groups, and other partners. During nearly three decades of 
partnership with CDC's Global Immunization Division, PAHO has made 
outstanding progress towards strengthening routine immunization and 
surveillance systems for polio, measles, rubella, and congenital 
rubella syndrome; including maintaining the revolving fund for the bulk 
purchase of vaccines for member countries; developing a strong platform 
for strengthening surveillance of other VPDs; and maintaining its 
polio-free certification since 1994, as well as verification of 
regional rubella and CRS elimination since 2015 and regional measles 
elimination since 2016.
    Summary of the award:
    Recipient: Pan-American Health Organization (PAHO).
    Purpose of the Award: The purpose of this award is to support 
strengthening immunization systems; ensuring polio free certification 
status; maintaining measles, rubella, and neonatal tetanus elimination; 
and prevention of other VPDs in the Americas region, in alignment with 
the US Government endorsed Global Polio Eradication Initiative, the 
Immunization Agenda 2030 and CDC's Global Immunization Strategic 
Framework 2021-2030. Additionally, this NOFO supports CDC's Global 
Health Strategy which focuses on protecting and improving the health, 
safety, security, and well-being of Americans by reducing morbidity and 
mortality worldwide; improving capabilities to prepare for and respond 
to infectious diseases and other emerging health threats and public 
health emergencies; and maximizing potential of CDC's global programs 
to achieve public health impact.
    Amount of Award: $8,000,000 in Federal fiscal year (FFY) 2024 
funds, with a total estimated $ 50,000,000 for the 5-year period of 
performance, subject to availability of funds. Funding amounts for 
years 2-5 will be set at continuation.
    Authority: This program is authorized under Section 307 of the PHS 
Act (42 U.S.C 242); section 317(k)(1) and (2) of the PHS Act (42 U.S.C. 
247b(k)(1) and (2).
    Period of Performance: May 1, 2024, through April 30, 2029.

    Dated: January 24, 2024.
Jamie Legier,
Acting Director, Office of Grants Services, Acting Chief Grants 
Management Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-02507 Filed 2-6-24; 8:45 am]
BILLING CODE 4163-18-P